RFA-DA-23-056 - Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

On This Page: 1

Active NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)

Expired NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)
Notice of Special Interest (NOSI): Chemical Countermeasures Research Program (CCRP) Initiative: Additional Research Areas of Interest focusing on Ultra-Potent Synthetic (UPS) Opioids NOT-DA-23-044 NIDA NIAID Oct 25, 2023 Nov 20, 2024 R01
For technical issues E-mail OER Webmaster